Training activity information
Details
Carry out an organisational risk assessment for a new injectable medicinal product and identify the appropriate location for preparation including any actions needed to mitigate risks
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee​.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- National guidance, including aseptic and wider legislation/guidance relating to this area
- Local standard operating procedures (SOPs)
- Local policy
- Practical application of legislation and guidance relating to aseptic products
- Risk assessment
- Risk management
- Capacity planning
- Action planning
- Organisational risk strategy including the wider clinical environment
- Communication with other HCPs
- Limits of practice
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 3 |
Outcome
Practice effective communication with a range of stakeholders using a variety of methods. |
| # 5 |
Outcome
Apply organisational policies in the workplace. |